Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Maki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Nutrition|March 1, 1992
Dietary lipids and immune functionP A Maki, P M Newberne
Biochemical Pharmacology|January 7, 1993
Sensitivity of aldehyde dehydrogenases in murine tumor and hematopoietic progenitor cells to inhibition by chloral hydrate as determined by the ability of chloral hydrate to potentiate the cytotoxic action of mafosfamideP A Maki, N E Sladek
Nutrition and Cancer|January 1, 1992
Humoral and cellular immune functions are not compromised by the anticarcinogenic Bowman-Birk inhibitorP A Maki, A R Kennedy
Cancer Research|August 15, 1991
Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazineP A Maki, N E Sladek
Nutrition and Cancer|January 1, 1994
Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeansP A Maki, Y Paterson, A R Kennedy
Cancer Biochemistry Biophysics|October 1, 1994
Effect of modifiers of arachidonic acid metabolism on radiation transformation and eicosanoid formation in C3H/10T1/2 cellsP C Billings, P A Maki, A R Kennedy
Nutrition and Cancer|January 1, 1993
Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBAA R Kennedy, P C Billings, P A Maki, et al.
Cancer Letters|March 15, 1992
Distribution of the Bowman Birk protease inhibitor in mice following oral administrationP C Billings, W H St Clair, P A Maki, et al.
Drug Metabolism Reviews|January 1, 1989
Xenobiotic oxidation catalyzed by aldehyde dehydrogenasesN E Sladek, C L Manthey, P A Maki, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Nutrition|March 1, 1992
Dietary lipids and immune functionP A Maki, P M Newberne
Biochemical Pharmacology|January 7, 1993
Sensitivity of aldehyde dehydrogenases in murine tumor and hematopoietic progenitor cells to inhibition by chloral hydrate as determined by the ability of chloral hydrate to potentiate the cytotoxic action of mafosfamideP A Maki, N E Sladek
Nutrition and Cancer|January 1, 1992
Humoral and cellular immune functions are not compromised by the anticarcinogenic Bowman-Birk inhibitorP A Maki, A R Kennedy
Cancer Research|August 15, 1991
Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazineP A Maki, N E Sladek
Nutrition and Cancer|January 1, 1994
Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeansP A Maki, Y Paterson, A R Kennedy
Cancer Biochemistry Biophysics|October 1, 1994
Effect of modifiers of arachidonic acid metabolism on radiation transformation and eicosanoid formation in C3H/10T1/2 cellsP C Billings, P A Maki, A R Kennedy
Nutrition and Cancer|January 1, 1993
Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBAA R Kennedy, P C Billings, P A Maki, et al.
Cancer Letters|March 15, 1992
Distribution of the Bowman Birk protease inhibitor in mice following oral administrationP C Billings, W H St Clair, P A Maki, et al.
Drug Metabolism Reviews|January 1, 1989
Xenobiotic oxidation catalyzed by aldehyde dehydrogenasesN E Sladek, C L Manthey, P A Maki, et al.
Pageof 1